Invasive Pneumococcal Disease and Pneumococcal Pneumonia
Authors:
- 1 March 2014
- journal article
- respiratory infections
- Published by Wolters Kluwer Health in Clinical Pulmonary Medicine
- Vol. 21 (2) , 76-80
Abstract
Invasive pneumococcal disease is defined as an infection confirmed by the isolation of Streptococcus pneumoniae from a normally sterile site. Its incidence in any population is affected by geographic location, time of year, serotype prevalence, age, and vaccination status, and in general invasive pneumococcal disease is more frequent in patients with certain underlying medical conditions or demographic risk factors. These include: age below 2 or 65 years and above; certain racial/ethnic groups; chronic cardiovascular, pulmonary, liver, or renal disease; diabetes mellitus; alcohol abuse; smoking; or immunosuppressive conditions. All over the world, routine vaccination in young children with pneumococcal conjugate vaccines causes significant decline in the incidence of invasive pneumococcal disease in children below 5 years (the age group targeted for vaccination), older children, and adults. As the mortality of pneumococcal pneumonia has not changed for many years despite the different available antimicrobial agents, prevention of pneumococcal infection by vaccination seems to be a rational approach to further decrease the public burden of the disease.Keywords
This publication has 11 references indexed in Scilit:
- Incidence of invasive pneumococcal disease among elderly people in Southern Catalonia, Spain, 2002–2009: An increase in serotypes not contained in the heptavalent conjugate vaccineJournal of Infection, 2011
- The persisting burden of invasive pneumococcal disease in HIV patients: an observational cohort studyBMC Infectious Diseases, 2011
- Mortality and associated risk factors in consecutive patients admitted to a UK NHS trust with community acquired bacteraemiaPostgraduate Medical Journal, 2011
- Management of Community-acquired Pneumonia in AdultsAmerican Journal of Respiratory and Critical Care Medicine, 2011
- Clinical and economic burden of community-acquired pneumonia among adults in EuropeThorax, 2010
- Capsular Types and Predicting Patient Outcomes in Pneumococcal BacteremiaClinical Infectious Diseases, 2007
- Impact of Pneumococcal Vaccination on Pneumonia Rates in Patients with COPD and AsthmaJournal of General Internal Medicine, 2007
- Antibacterial drug resistance: implications for the treatment of patients with community-acquired pneumoniaInfectious Disease Clinics of North America, 2004
- Streptococcus pneumoniae colonisation: the key to pneumococcal diseaseThe Lancet Infectious Diseases, 2004
- Recurrent Pneumococcal BacteremiaArchives of internal medicine (1960), 2001